These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4415589)

  • 21. [A case of vitamin-resistant hypophosphoremic osteomalacia in an adult: effect of thyrocalcitonin and course under vitamin-phosphorus treatment].
    Renier JC; Boasson M; Jallet P
    Rhumatologie; 1972; 24(7):247-56. PubMed ID: 4540381
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of vitamin D 2 and 25-hydroxycholecalciferol on intestinal absorption of radiophosphate in man].
    Gennari C; Vattimo A; Nardi P
    Boll Soc Ital Biol Sper; 1975 Feb; 51(3):86-9. PubMed ID: 1080052
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of estrogen and progesterone on feed intake and hydroxyproline excretion following induced hypocalcemia in dairy cows.
    Muir LA; Hibbs JW; Conrad HR; Smith KL
    J Dairy Sci; 1972 Nov; 55(11):1613-20. PubMed ID: 4628961
    [No Abstract]   [Full Text] [Related]  

  • 25. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.
    Brickman AS; Coburn JW; Kurokawa K; Bethune JE; Harrison HE; Norman AW
    N Engl J Med; 1973 Sep; 289(10):495-8. PubMed ID: 4353218
    [No Abstract]   [Full Text] [Related]  

  • 26. Adult-onset vitamin-D-resistant hypophosphatemic osteomalacia. Effect of total parathyroidectomy.
    Riggs BL; Sprague RG; Jowsey J; Maher FT
    N Engl J Med; 1969 Oct; 281(14):762-6. PubMed ID: 5807923
    [No Abstract]   [Full Text] [Related]  

  • 27. The osteomalacia syndrome after stomach operations.
    Morgan DB; Hunt G; Paterson CR
    Q J Med; 1970 Jul; 39(155):395-410. PubMed ID: 5478508
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
    Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis.
    Young MM; Jasani C; Smith DA; Nordin BE
    Clin Sci; 1968 Jun; 34(3):411-7. PubMed ID: 5666871
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distortions of bone cell metabolism in uremia and their cause.
    Nichols G; Flanagan B; Veer Jv
    Arch Intern Med; 1969 Nov; 124(5):530-8. PubMed ID: 5345859
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
    Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
    Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3.
    Compston JE; Crowe JP; Horton LW
    Br Med J; 1979 Aug; 2(6185):309. PubMed ID: 476441
    [No Abstract]   [Full Text] [Related]  

  • 34. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
    Pierides AM; Ellis HA; Simpson W; Dewar JH; Ward MK; Kerr DN
    Lancet; 1976 May; 1(7969):1092-5. PubMed ID: 57505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone and ageing.
    Dequeker J
    Ann Rheum Dis; 1975 Feb; 34(1):100-15. PubMed ID: 164839
    [No Abstract]   [Full Text] [Related]  

  • 36. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous vitamin D on bone and phosphate metabolism in osteomalacia.
    Bordier P; Hioco D; Rouquier M; Hepner GW; Thompson GR
    Calcif Tissue Res; 1969 Aug; 4(1):78-83. PubMed ID: 5344411
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.
    Cuthbert JA; Pak CY; Zerwekh JE; Glass KD; Combes B
    Hepatology; 1984; 4(1):1-8. PubMed ID: 6693061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
    Lindholm TS; Nilsson OS; Widhe T; Elmsted E; Eriksson S
    Acta Vitaminol Enzymol; 1982; 4(1-2):179-84. PubMed ID: 7124565
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Osteomalacia.
    Aaron J; Gallagher JC; Nordin BE
    Lancet; 1974 May; 1(7863):939. PubMed ID: 4133471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.